High cho­les­terol con­tender Es­pe­ri­on slips on safe­ty con­cerns, stock sinks 30%

Es­pe­ri­on’s stock is slid­ing south Wednes­day morn­ing fol­low­ing news that the com­pa­ny’s high cho­les­terol drug may have some safe­ty con­cerns.

Over­all, the com­pa­ny re­port­ed pos­i­tive …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER